Form 4: NHC CEO Stephen Flatt Receives New Stock Option Grant

NATIONAL HEALTHCARE CORP CEO and Director Stephen Flatt reported a new grant of 20,000 stock options with a vesting schedule over three years.

Summary

• Stephen Fowler Flatt, CEO and Director of NATIONAL HEALTHCARE CORP (NHC), reported changes in his beneficial ownership.
• He directly beneficially owns 59,147 shares of Common Stock.
• On February 23, 2026, he was granted 20,000 stock options under the 2020 Omnibus Equity Incentive Plan, with an exercise price of $157.13.
• These new options will vest ratably over three years: one-third on February 23, 2027; one-third on February 23, 2028; and the final one-third on February 23, 2029.
• He also holds previously granted options: 6,147 options exercisable at $53.94 (expiring March 8, 2028), 10,000 options exercisable at $94.1 (expiring March 5, 2029), and 18,000 options exercisable at $90.62 (expiring February 28, 2030).
• Following these reported transactions, he beneficially owns a total of 59,147 shares of common stock and 54,147 stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine executive compensation event, aligning management's long-term interests with shareholder value through equity ownership, which is generally a positive governance practice.

Positives

• The grant of 20,000 stock options aligns the CEO's long-term interests with shareholder value.
• The options are granted under an existing 2020 Omnibus Equity Incentive Plan, indicating a structured approach to executive compensation.

Negatives

• The newly granted options are not immediately exercisable and vest over a three-year period, meaning no immediate financial gain.
• The exercise price of $157.13 for the new options is higher than the exercise prices of some previously granted options, requiring significant stock price appreciation for maximum value.

Risks

• The value of the stock options is subject to market price fluctuations of NATIONAL HEALTHCARE CORP common stock.
• If the stock price does not exceed the exercise price by the vesting and expiration dates, the options may expire worthless.

Future Outlook

The future outlook for Stephen Flatt's equity compensation includes the vesting of 20,000 stock options over the next three years, with one-third becoming exercisable annually from February 23, 2027, through February 23, 2029. The value of these options will depend on the future market performance of NATIONAL HEALTHCARE CORP's common stock relative to the $157.13 exercise price.

Industry Context

StockSavvy.ai notes that the grant of stock options to executive officers like Stephen Flatt is a common practice across industries, particularly in healthcare, to incentivize long-term performance and align management's financial interests with those of shareholders. This type of equity compensation is a standard component of executive pay packages designed to foster commitment to the company's sustained growth and profitability.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased alignment of management's interests with long-term shareholder value through equity ownership.
• Employees: No direct impact on general employees mentioned in this filing.

Next Steps

• One-third of the 20,000 newly granted stock options will vest on February 23, 2027.
• One-third of the 20,000 newly granted stock options will vest on February 23, 2028.
• The final one-third of the 20,000 newly granted stock options will vest on February 23, 2029.

Key Dates

Recommendation

This Form 4 reports a routine executive stock option grant, which is a standard component of compensation and aligns management interests with shareholders. It does not provide new fundamental information to alter an investment thesis, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

NATIONAL HEALTHCARE CORP, NHC, Stephen Flatt, Form 4, Stock Options, Equity Incentive Plan, Insider Transaction, CEO, Director, Beneficial Ownership